N Osheroff Selected Research

N Osheroff Research Topics

7	Neoplasms (Cancer) 07/2005 - 01/2000
4	Leukemia 07/2005 - 08/2000
2	Genetic Translocation (Chromosomal Translocation) 01/2011 - 07/2005
2	Chromosome Breakage 02/2001 - 01/2001
1	Multiple Sclerosis 01/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2001
1	Virus Diseases (Viral Diseases) 06/2001
1	Infections 03/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2001
1	Poisoning 01/2000

6	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2005 - 01/2000
4	Etoposide (VP 16)FDA LinkGeneric 07/2005 - 01/2001
4	EnzymesIBA 07/2005 - 01/2000
3	Pharmaceutical PreparationsIBA 08/2001 - 08/2000
2	Antineoplastic Agents (Antineoplastics)IBA 01/2001 - 08/2000
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2005
1	Dactinomycin (Actinomycin)FDA LinkGeneric 08/2001
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2001
1	QuinolonesIBA 03/2001
1	TOP 53IBA 01/2001
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2000
1	6- ((2- (dimethylamino)ethyl)amino)- 3- hydroxy- 7H- indeno(2,1- c)quinolin- 7- oneIBA 08/2000
1	Synthetic DrugsIBA 08/2000
1	IodidesIBA 08/2000
1	4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA 01/2000

1	Drug Therapy (Chemotherapy) 07/2005